Navigation Links
CRISPR Generated Models: A Framework for Reducing Risk and Timelines Through Careful Design and Planning for Downstream Services, Upcoming Webinar Hosted by Xtalks
Date:6/19/2020

Join experts from Envigo Lauren Klaskala, Project Manager – Custom Transgenic Models and Justin Zhao, PhD, Principal Scientist in a live webinar on Wednesday, July 8, 2020 at 11am EDT (4pm BST/UK).

Nuclease-based technologies such as CRISPR and ZFN have simplified the way we genetically engineer new models. However, while modifying the genome may be more straightforward, the challenge to create an optimal model for the desired application remains. Creating reliable animal models for long-term studies can often be problematic, not necessarily due to the complexity of the genetic modification(s) required, but with how that genetic modification will perform in the model. Suboptimal design strategies can compound these challenges by generating undesired genotypic or phenotypic results thus producing an ineffective model.

CRISPR-Cas9 or zinc-finger nuclease (ZFN)-based technologies can circumvent the challenges of complex genetic alterations due to their precision. When focusing on what the exact need or application will be for the model, optimal designs can be determined that then yield a reliable model for its specific application. Whether the modification to be produced is a humanization, replacement, conditional knockout, constitutive knockout, large deletion, point mutation, cDNA insertion, or reporter tagging, if careful consideration is given to the goal for the model usage and application, then optimal designs yield superior models.

When considering new model creation and development, scientists often focus on generating the model itself and overlook the downstream services required afterward, including initial model characterization, cryopreservation, breeding, and colony expansion. Envigo is the scientist alongside their customers – taking in all considerations for the model application and all the products and services needed to create, develop, and maintain the model.

For more information or to register for this event, visit CRISPR Generated Models: A Framework for Reducing Risk and Timelines Through Careful Design and Planning for Downstream Services.

ABOUT ENVIGO

Envigo provides the broadest range of research models and related services to the pharmaceutical and biotechnology industries, government, academia, and other life science organizations. As the largest organization that is solely dedicated to providing research models and related products and services, we are committed to helping researchers realize the full potential of their critical R&D projects as we fulfill our mission to work together to build a healthier and safer world. Read more at envigo.com.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:
Sydney Perelmutter
Tel: +1 (416) 977-6555 x 352
Email: sperelmutter@xtalks.com

Read the full story at https://www.prweb.com/releases/crispr_generated_models_a_framework_for_reducing_risk_and_timelines_through_careful_design_and_planning_for_downstream_services_upcoming_webinar_hosted_by_xtalks/prweb17201574.htm.


'/>"/>
Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved


Related biology news :

1. Shortening guide RNA markedly improves specificity of CRISPR-Cas nucleases
2. CRISPR system can promote antibiotic resistance
3. CELLECTA, INC. Announces Launch of Human Whole Genome CRISPR Knockout Library
4. Plum Alley Closes $1.5M in Syndicate with Women and Men Investing in CRISPR-based Diagnostics Company
5. Horizon Discovery Presents an Educational Webinar on CRISPR-Cas9 Genome Engineering in Primary T cells
6. Asymmetrex Suggests a Stemgene Relief from Recent Cancer Woes About CRISPR-Cas9 Gene-Editing Therapies
7. CRISPR Cas9 Genome Editing Market Worth $5.3 Billion by 2025
8. CRISPR-Chip Enables Digital Detection of DNA without Amplification
9. Book explores place-based conservation as framework
10. New framework to deliver biodiversity knowledge
11. Researchers at Penn show optimal framework for heartbeats
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2020)... ... June 16, 2020 , ... The director of stem cell biotechnology ... the stem cell medicine and pharmaceutical industries have easier access to stem cell counting, ... July 5 of this year, Independence Day weekend in the U.S., Asymmetrex is offering ...
(Date:6/19/2020)... TORONTO (PRWEB) , ... June 18, 2020 , ... Join ... Justin Zhao, PhD, Principal Scientist in a live webinar on Wednesday, July ... ZFN have simplified the way we genetically engineer new models. However, while modifying the ...
(Date:6/11/2020)... ... June 08, 2020 , ... Cryo-Cell International’s announcement ... to protect workers in the medical field. The face masks will be distributed ... their lives every day to provide healthcare to pregnant women. The delivery of ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... ... July 17, 2020 , ... dicentra , ... sciences and food industries, is pleased to announce that Charles Galea has joined ... Development. , Charles is an accomplished and results-driven sales executive with over 10 ...
(Date:7/10/2020)... ... 2020 , ... Sentien Biotechnologies, Inc., a clinical-stage biotechnology company ... Nissenson, M.D., F.A.C.P., as its Chief Medical Officer. Dr. Nissenson will join ... Dr. Nissenson serves as an Emeritus Professor of Medicine at the David ...
(Date:7/1/2020)... ... June 29, 2020 , ... The ... purchasing contracts to its membership, recently named BioFit Engineered Products an ... opportunity to purchase ergonomic seating, cafeteria tables, book trucks and carts at discounted ...
(Date:6/28/2020)... HILL, Conn. (PRWEB) , ... June 25, 2020 ... ... company formed to advance photodynamic therapy for treating cancer, today announced the company ... New York (“Roswell Park”). The agreement provides Lumeda globally exclusive rights to ...
Breaking Biology Technology: